HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
10.68
-0.71 (-6.23%)
Jul 30, 2026, 2:01 PM EDT - Market open
HUTCHMED (China) Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 549.12 | 548.51 | 630.2 | 838 | 426.41 | 356.13 | |
Revenue Growth | 0.11% | -12.96% | -24.80% | 96.53% | 19.73% | 56.21% |
Cost of Revenue | 320.93 | 336.35 | 348.88 | 384.45 | 311.1 | 258.23 |
Gross Profit | 228.19 | 212.16 | 281.32 | 453.55 | 115.31 | 97.89 |
Selling, General & Admin | 107.88 | 103.03 | 112.91 | 133.18 | 136.11 | 127.13 |
Research & Development | 155.09 | 148.3 | 212.11 | 302 | 386.89 | 299.09 |
Total Operating Expenses | 262.97 | 251.32 | 325.02 | 435.18 | 523 | 426.21 |
Operating Income | -34.78 | -39.16 | -43.71 | 18.38 | -407.69 | -328.32 |
Interest Income | - | 49.88 | 40.08 | 36.15 | 9.6 | 2.08 |
Interest Expense | - | -2.87 | -2.87 | -0.76 | -0.65 | -0.59 |
Other Non-Operating Income (Expense) | 2.76 | 513.49 | 51.86 | 51.84 | 38.08 | 171.71 |
Total Non-Operating Income (Expense) | 2.76 | 560.5 | 89.07 | 87.23 | 47.02 | 173.19 |
Pretax Income | -32.01 | 521.34 | 45.36 | 105.6 | -360.67 | -155.12 |
Provision for Income Taxes | 1.66 | 63.61 | 7.19 | 4.51 | -0.28 | 11.92 |
Net Income | -33.67 | 457.73 | 38.17 | 101.09 | -360.39 | -167.04 |
Minority Interest in Earnings | 0.54 | 0.82 | 0.44 | 0.31 | 0.45 | 27.61 |
Net Income to Common | 17.88 | 456.91 | 37.73 | 100.78 | -360.84 | -194.65 |
Net Income Growth | -96.09% | 1111.03% | -62.56% | - | - | - |
Shares Outstanding (Basic) | 173 | 172 | 171 | 170 | 169 | 159 |
Shares Outstanding (Diluted) | 175 | 175 | 175 | 174 | 169 | 159 |
Shares Change | 0.02% | 0.01% | 0.42% | 2.60% | 6.87% | 13.58% |
EPS (Basic) | 0.10 | 2.65 | 0.20 | 0.60 | -2.15 | -1.25 |
EPS (Diluted) | 0.10 | 2.60 | 0.20 | 0.60 | -2.15 | -1.25 |
EPS Growth | -96.15% | 1200.00% | -66.67% | - | - | - |
Free Cash Flow | 9.95 | -78.81 | -17.44 | 186.65 | -305.26 | -220.62 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | 0.06 | -0.45 | -0.10 | 1.07 | -1.80 | -1.39 |
Gross Margin | 41.56% | 38.68% | 44.64% | 54.12% | 27.04% | 27.49% |
Operating Margin | -6.33% | -7.14% | -6.94% | 2.19% | -95.61% | -92.19% |
Profit Margin | -6.13% | 83.45% | 6.06% | 12.06% | -84.52% | -46.90% |
FCF Margin | 1.81% | -14.37% | -2.77% | 22.27% | -71.59% | -61.95% |
EBITDA | -20.52 | -25.85 | -31.36 | 26.58 | -399.03 | -321.13 |
EBITDA Margin | -3.74% | -4.71% | -4.98% | 3.17% | -93.58% | -90.17% |
EBIT | -34.78 | -39.16 | -43.71 | 18.38 | -407.69 | -328.32 |
EBIT Margin | -6.33% | -7.14% | -6.94% | 2.19% | -95.61% | -92.19% |
Effective Tax Rate | -5.18% | 12.20% | 15.85% | 4.27% | 0.08% | -7.68% |